Bristol, Sanofi and Novartis drugs to shine among 2015 launches

March 23, 2015 1:50 PM

17 0

LONDON (Reuters) - Bristol-Myers Squibb, Sanofi and Novartis have the three top new drugs set to reach the market in 2015, among 11 products each with $1 billion-plus sales potential, according to a Thomson Reuters analysis.

More potential blockbusters are expected to be launched this year than last, in an encouraging sign for the pharmaceutical industry, which relies on new products to replenish sales as older medicines go off patent.

Read more

To category page